A Study to Investigate PK, Safety, Tolerability of Cefepime-enmetazobactam in Pediatric Participants With cUTI
Not yet recruiting
Linical Co., Ltd.
Phase 2
2023-04-15
This phase 2 study is part of regulatory commitments in the United States (PSP) and Europe
(PIP) to evaluate cefepime-enmetazobactam in paediatric participants with cUTI to support
extension of the indication for cefepime-enmetazobactam to children with cUTI.
A Study to Investigate PK, Safety, Tolerability of Cefepime-enmetazobactam in Pediatric Participants With cUTI
Not yet recruiting
Allecra
Phase 2
2023-04-15
This phase 2 study is part of regulatory commitments in the United States (PSP) and Europe
(PIP) to evaluate cefepime-enmetazobactam in paediatric participants with cUTI to support
extension of the indication for cefepime-enmetazobactam to children with cUTI.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
